Global Cell and Gene Therapy Supply Chain and Logistics Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global Cell and Gene Therapy Supply Chain and Logistics Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Page: 142

Published Date: 29 Jan 2024

Category: Service & Software

PDF Download

Get FREE Sample

Customize Request

  • sp_icon1 sp_icon1_b Description
  • sp_icon2 sp_icon2_b Table of Contents
  • sp_icon3 sp_icon3_b Table of Figures
  • sp_icon4 sp_icon4_b Research Methodology
  • sp_icon1 sp_icon1_b Companies Mentioned
  • sp_icon1 sp_icon1_b Related Reports
  • sp_icon1 sp_icon1_b Product Tags
btl

Description

According to our (Global Info Research) latest study, the global Cell and Gene Therapy Supply Chain and Logistics market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

Cell and Gene Therapy Supply Chain and Logistics refer to the specialized processes and systems involved in managing the transportation, storage, and distribution of cell and gene therapy products. These therapies are often temperature-sensitive and require precise handling and monitoring.

Cell and Gene Therapy Supply Chain and Logistics: With the rapid growth of cell and gene therapy development, there is a heightened focus on building robust and secure supply chains. Trends include the use of advanced tracking and monitoring technologies, cold chain logistics, and specialized packaging to ensure the safe and efficient delivery of these therapies to patients.

The Global Info Research report includes an overview of the development of the Cell and Gene Therapy Supply Chain and Logistics industry chain, the market status of Biobank (Ordering and Scheduling Services, Sample Collection Services), Cell Therapy Lab (Ordering and Scheduling Services, Sample Collection Services), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Cell and Gene Therapy Supply Chain and Logistics.

Regionally, the report analyzes the Cell and Gene Therapy Supply Chain and Logistics markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Cell and Gene Therapy Supply Chain and Logistics market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:
The report presents comprehensive understanding of the Cell and Gene Therapy Supply Chain and Logistics market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Cell and Gene Therapy Supply Chain and Logistics industry.

The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Ordering and Scheduling Services, Sample Collection Services).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Cell and Gene Therapy Supply Chain and Logistics market.

Regional Analysis: The report involves examining the Cell and Gene Therapy Supply Chain and Logistics market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Cell and Gene Therapy Supply Chain and Logistics market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to Cell and Gene Therapy Supply Chain and Logistics:
Company Analysis: Report covers individual Cell and Gene Therapy Supply Chain and Logistics players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Cell and Gene Therapy Supply Chain and Logistics This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Biobank, Cell Therapy Lab).

Technology Analysis: Report covers specific technologies relevant to Cell and Gene Therapy Supply Chain and Logistics. It assesses the current state, advancements, and potential future developments in Cell and Gene Therapy Supply Chain and Logistics areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Cell and Gene Therapy Supply Chain and Logistics market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation
Cell and Gene Therapy Supply Chain and Logistics market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.

Market segment by Type
Ordering and Scheduling Services
Sample Collection Services
Logistics Services
Post Treatment Follow-Up Services

Market segment by Application
Biobank
Cell Therapy Lab
Hospital
Research Institute

Market segment by players, this report covers
Be The Match BioTherapies
Biocair
Marken
World Courier
MAK-SYSTEM
Cryoport
Brooks Life Sciences
Clarkston Consulting
Hypertrust Patient Data Care
Haemonetics
MasterControl
TraceLink
SAVSU Technologies
TrakCel
Title21 Health Solutions
sedApta Group
Vineti
Stafa Cellular Therapy
Thermo Fisher Scientific
McKesson
BioLife Solutions

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Cell and Gene Therapy Supply Chain and Logistics product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Cell and Gene Therapy Supply Chain and Logistics, with revenue, gross margin and global market share of Cell and Gene Therapy Supply Chain and Logistics from 2019 to 2024.
Chapter 3, the Cell and Gene Therapy Supply Chain and Logistics competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Cell and Gene Therapy Supply Chain and Logistics market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Cell and Gene Therapy Supply Chain and Logistics.
Chapter 13, to describe Cell and Gene Therapy Supply Chain and Logistics research findings and conclusion.
btl

Table of Contents

1 Market Overview
1.1 Product Overview and Scope of Cell and Gene Therapy Supply Chain and Logistics
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Cell and Gene Therapy Supply Chain and Logistics by Type
1.3.1 Overview: Global Cell and Gene Therapy Supply Chain and Logistics Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Cell and Gene Therapy Supply Chain and Logistics Consumption Value Market Share by Type in 2023
1.3.3 Ordering and Scheduling Services
1.3.4 Sample Collection Services
1.3.5 Logistics Services
1.3.6 Post Treatment Follow-Up Services
1.4 Global Cell and Gene Therapy Supply Chain and Logistics Market by Application
1.4.1 Overview: Global Cell and Gene Therapy Supply Chain and Logistics Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Biobank
1.4.3 Cell Therapy Lab
1.4.4 Hospital
1.4.5 Research Institute
1.5 Global Cell and Gene Therapy Supply Chain and Logistics Market Size & Forecast
1.6 Global Cell and Gene Therapy Supply Chain and Logistics Market Size and Forecast by Region
1.6.1 Global Cell and Gene Therapy Supply Chain and Logistics Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Cell and Gene Therapy Supply Chain and Logistics Market Size by Region, (2019-2030)
1.6.3 North America Cell and Gene Therapy Supply Chain and Logistics Market Size and Prospect (2019-2030)
1.6.4 Europe Cell and Gene Therapy Supply Chain and Logistics Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Cell and Gene Therapy Supply Chain and Logistics Market Size and Prospect (2019-2030)
1.6.6 South America Cell and Gene Therapy Supply Chain and Logistics Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Cell and Gene Therapy Supply Chain and Logistics Market Size and Prospect (2019-2030)

2 Company Profiles
2.1 Be The Match BioTherapies
2.1.1 Be The Match BioTherapies Details
2.1.2 Be The Match BioTherapies Major Business
2.1.3 Be The Match BioTherapies Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
2.1.4 Be The Match BioTherapies Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Be The Match BioTherapies Recent Developments and Future Plans
2.2 Biocair
2.2.1 Biocair Details
2.2.2 Biocair Major Business
2.2.3 Biocair Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
2.2.4 Biocair Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Biocair Recent Developments and Future Plans
2.3 Marken
2.3.1 Marken Details
2.3.2 Marken Major Business
2.3.3 Marken Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
2.3.4 Marken Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Marken Recent Developments and Future Plans
2.4 World Courier
2.4.1 World Courier Details
2.4.2 World Courier Major Business
2.4.3 World Courier Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
2.4.4 World Courier Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 World Courier Recent Developments and Future Plans
2.5 MAK-SYSTEM
2.5.1 MAK-SYSTEM Details
2.5.2 MAK-SYSTEM Major Business
2.5.3 MAK-SYSTEM Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
2.5.4 MAK-SYSTEM Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 MAK-SYSTEM Recent Developments and Future Plans
2.6 Cryoport
2.6.1 Cryoport Details
2.6.2 Cryoport Major Business
2.6.3 Cryoport Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
2.6.4 Cryoport Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Cryoport Recent Developments and Future Plans
2.7 Brooks Life Sciences
2.7.1 Brooks Life Sciences Details
2.7.2 Brooks Life Sciences Major Business
2.7.3 Brooks Life Sciences Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
2.7.4 Brooks Life Sciences Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Brooks Life Sciences Recent Developments and Future Plans
2.8 Clarkston Consulting
2.8.1 Clarkston Consulting Details
2.8.2 Clarkston Consulting Major Business
2.8.3 Clarkston Consulting Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
2.8.4 Clarkston Consulting Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Clarkston Consulting Recent Developments and Future Plans
2.9 Hypertrust Patient Data Care
2.9.1 Hypertrust Patient Data Care Details
2.9.2 Hypertrust Patient Data Care Major Business
2.9.3 Hypertrust Patient Data Care Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
2.9.4 Hypertrust Patient Data Care Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Hypertrust Patient Data Care Recent Developments and Future Plans
2.10 Haemonetics
2.10.1 Haemonetics Details
2.10.2 Haemonetics Major Business
2.10.3 Haemonetics Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
2.10.4 Haemonetics Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Haemonetics Recent Developments and Future Plans
2.11 MasterControl
2.11.1 MasterControl Details
2.11.2 MasterControl Major Business
2.11.3 MasterControl Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
2.11.4 MasterControl Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 MasterControl Recent Developments and Future Plans
2.12 TraceLink
2.12.1 TraceLink Details
2.12.2 TraceLink Major Business
2.12.3 TraceLink Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
2.12.4 TraceLink Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 TraceLink Recent Developments and Future Plans
2.13 SAVSU Technologies
2.13.1 SAVSU Technologies Details
2.13.2 SAVSU Technologies Major Business
2.13.3 SAVSU Technologies Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
2.13.4 SAVSU Technologies Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 SAVSU Technologies Recent Developments and Future Plans
2.14 TrakCel
2.14.1 TrakCel Details
2.14.2 TrakCel Major Business
2.14.3 TrakCel Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
2.14.4 TrakCel Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2019-2024)
2.14.5 TrakCel Recent Developments and Future Plans
2.15 Title21 Health Solutions
2.15.1 Title21 Health Solutions Details
2.15.2 Title21 Health Solutions Major Business
2.15.3 Title21 Health Solutions Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
2.15.4 Title21 Health Solutions Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2019-2024)
2.15.5 Title21 Health Solutions Recent Developments and Future Plans
2.16 sedApta Group
2.16.1 sedApta Group Details
2.16.2 sedApta Group Major Business
2.16.3 sedApta Group Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
2.16.4 sedApta Group Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2019-2024)
2.16.5 sedApta Group Recent Developments and Future Plans
2.17 Vineti
2.17.1 Vineti Details
2.17.2 Vineti Major Business
2.17.3 Vineti Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
2.17.4 Vineti Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2019-2024)
2.17.5 Vineti Recent Developments and Future Plans
2.18 Stafa Cellular Therapy
2.18.1 Stafa Cellular Therapy Details
2.18.2 Stafa Cellular Therapy Major Business
2.18.3 Stafa Cellular Therapy Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
2.18.4 Stafa Cellular Therapy Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2019-2024)
2.18.5 Stafa Cellular Therapy Recent Developments and Future Plans
2.19 Thermo Fisher Scientific
2.19.1 Thermo Fisher Scientific Details
2.19.2 Thermo Fisher Scientific Major Business
2.19.3 Thermo Fisher Scientific Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
2.19.4 Thermo Fisher Scientific Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2019-2024)
2.19.5 Thermo Fisher Scientific Recent Developments and Future Plans
2.20 McKesson
2.20.1 McKesson Details
2.20.2 McKesson Major Business
2.20.3 McKesson Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
2.20.4 McKesson Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2019-2024)
2.20.5 McKesson Recent Developments and Future Plans
2.21 BioLife Solutions
2.21.1 BioLife Solutions Details
2.21.2 BioLife Solutions Major Business
2.21.3 BioLife Solutions Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
2.21.4 BioLife Solutions Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2019-2024)
2.21.5 BioLife Solutions Recent Developments and Future Plans

3 Market Competition, by Players
3.1 Global Cell and Gene Therapy Supply Chain and Logistics Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Cell and Gene Therapy Supply Chain and Logistics by Company Revenue
3.2.2 Top 3 Cell and Gene Therapy Supply Chain and Logistics Players Market Share in 2023
3.2.3 Top 6 Cell and Gene Therapy Supply Chain and Logistics Players Market Share in 2023
3.3 Cell and Gene Therapy Supply Chain and Logistics Market: Overall Company Footprint Analysis
3.3.1 Cell and Gene Therapy Supply Chain and Logistics Market: Region Footprint
3.3.2 Cell and Gene Therapy Supply Chain and Logistics Market: Company Product Type Footprint
3.3.3 Cell and Gene Therapy Supply Chain and Logistics Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type
4.1 Global Cell and Gene Therapy Supply Chain and Logistics Consumption Value and Market Share by Type (2019-2024)
4.2 Global Cell and Gene Therapy Supply Chain and Logistics Market Forecast by Type (2025-2030)

5 Market Size Segment by Application
5.1 Global Cell and Gene Therapy Supply Chain and Logistics Consumption Value Market Share by Application (2019-2024)
5.2 Global Cell and Gene Therapy Supply Chain and Logistics Market Forecast by Application (2025-2030)

6 North America
6.1 North America Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Type (2019-2030)
6.2 North America Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Application (2019-2030)
6.3 North America Cell and Gene Therapy Supply Chain and Logistics Market Size by Country
6.3.1 North America Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Country (2019-2030)
6.3.2 United States Cell and Gene Therapy Supply Chain and Logistics Market Size and Forecast (2019-2030)
6.3.3 Canada Cell and Gene Therapy Supply Chain and Logistics Market Size and Forecast (2019-2030)
6.3.4 Mexico Cell and Gene Therapy Supply Chain and Logistics Market Size and Forecast (2019-2030)

7 Europe
7.1 Europe Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Type (2019-2030)
7.2 Europe Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Application (2019-2030)
7.3 Europe Cell and Gene Therapy Supply Chain and Logistics Market Size by Country
7.3.1 Europe Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Country (2019-2030)
7.3.2 Germany Cell and Gene Therapy Supply Chain and Logistics Market Size and Forecast (2019-2030)
7.3.3 France Cell and Gene Therapy Supply Chain and Logistics Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Cell and Gene Therapy Supply Chain and Logistics Market Size and Forecast (2019-2030)
7.3.5 Russia Cell and Gene Therapy Supply Chain and Logistics Market Size and Forecast (2019-2030)
7.3.6 Italy Cell and Gene Therapy Supply Chain and Logistics Market Size and Forecast (2019-2030)

8 Asia-Pacific
8.1 Asia-Pacific Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Cell and Gene Therapy Supply Chain and Logistics Market Size by Region
8.3.1 Asia-Pacific Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Region (2019-2030)
8.3.2 China Cell and Gene Therapy Supply Chain and Logistics Market Size and Forecast (2019-2030)
8.3.3 Japan Cell and Gene Therapy Supply Chain and Logistics Market Size and Forecast (2019-2030)
8.3.4 South Korea Cell and Gene Therapy Supply Chain and Logistics Market Size and Forecast (2019-2030)
8.3.5 India Cell and Gene Therapy Supply Chain and Logistics Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Cell and Gene Therapy Supply Chain and Logistics Market Size and Forecast (2019-2030)
8.3.7 Australia Cell and Gene Therapy Supply Chain and Logistics Market Size and Forecast (2019-2030)

9 South America
9.1 South America Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Type (2019-2030)
9.2 South America Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Application (2019-2030)
9.3 South America Cell and Gene Therapy Supply Chain and Logistics Market Size by Country
9.3.1 South America Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Country (2019-2030)
9.3.2 Brazil Cell and Gene Therapy Supply Chain and Logistics Market Size and Forecast (2019-2030)
9.3.3 Argentina Cell and Gene Therapy Supply Chain and Logistics Market Size and Forecast (2019-2030)

10 Middle East & Africa
10.1 Middle East & Africa Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Cell and Gene Therapy Supply Chain and Logistics Market Size by Country
10.3.1 Middle East & Africa Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Country (2019-2030)
10.3.2 Turkey Cell and Gene Therapy Supply Chain and Logistics Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Cell and Gene Therapy Supply Chain and Logistics Market Size and Forecast (2019-2030)
10.3.4 UAE Cell and Gene Therapy Supply Chain and Logistics Market Size and Forecast (2019-2030)

11 Market Dynamics
11.1 Cell and Gene Therapy Supply Chain and Logistics Market Drivers
11.2 Cell and Gene Therapy Supply Chain and Logistics Market Restraints
11.3 Cell and Gene Therapy Supply Chain and Logistics Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry

12 Industry Chain Analysis
12.1 Cell and Gene Therapy Supply Chain and Logistics Industry Chain
12.2 Cell and Gene Therapy Supply Chain and Logistics Upstream Analysis
12.3 Cell and Gene Therapy Supply Chain and Logistics Midstream Analysis
12.4 Cell and Gene Therapy Supply Chain and Logistics Downstream Analysis

13 Research Findings and Conclusion

14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. Global Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Region (2025-2030) & (USD Million)
Table 5. Be The Match BioTherapies Company Information, Head Office, and Major Competitors
Table 6. Be The Match BioTherapies Major Business
Table 7. Be The Match BioTherapies Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
Table 8. Be The Match BioTherapies Cell and Gene Therapy Supply Chain and Logistics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. Be The Match BioTherapies Recent Developments and Future Plans
Table 10. Biocair Company Information, Head Office, and Major Competitors
Table 11. Biocair Major Business
Table 12. Biocair Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
Table 13. Biocair Cell and Gene Therapy Supply Chain and Logistics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. Biocair Recent Developments and Future Plans
Table 15. Marken Company Information, Head Office, and Major Competitors
Table 16. Marken Major Business
Table 17. Marken Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
Table 18. Marken Cell and Gene Therapy Supply Chain and Logistics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. Marken Recent Developments and Future Plans
Table 20. World Courier Company Information, Head Office, and Major Competitors
Table 21. World Courier Major Business
Table 22. World Courier Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
Table 23. World Courier Cell and Gene Therapy Supply Chain and Logistics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. World Courier Recent Developments and Future Plans
Table 25. MAK-SYSTEM Company Information, Head Office, and Major Competitors
Table 26. MAK-SYSTEM Major Business
Table 27. MAK-SYSTEM Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
Table 28. MAK-SYSTEM Cell and Gene Therapy Supply Chain and Logistics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. MAK-SYSTEM Recent Developments and Future Plans
Table 30. Cryoport Company Information, Head Office, and Major Competitors
Table 31. Cryoport Major Business
Table 32. Cryoport Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
Table 33. Cryoport Cell and Gene Therapy Supply Chain and Logistics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. Cryoport Recent Developments and Future Plans
Table 35. Brooks Life Sciences Company Information, Head Office, and Major Competitors
Table 36. Brooks Life Sciences Major Business
Table 37. Brooks Life Sciences Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
Table 38. Brooks Life Sciences Cell and Gene Therapy Supply Chain and Logistics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 39. Brooks Life Sciences Recent Developments and Future Plans
Table 40. Clarkston Consulting Company Information, Head Office, and Major Competitors
Table 41. Clarkston Consulting Major Business
Table 42. Clarkston Consulting Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
Table 43. Clarkston Consulting Cell and Gene Therapy Supply Chain and Logistics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 44. Clarkston Consulting Recent Developments and Future Plans
Table 45. Hypertrust Patient Data Care Company Information, Head Office, and Major Competitors
Table 46. Hypertrust Patient Data Care Major Business
Table 47. Hypertrust Patient Data Care Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
Table 48. Hypertrust Patient Data Care Cell and Gene Therapy Supply Chain and Logistics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 49. Hypertrust Patient Data Care Recent Developments and Future Plans
Table 50. Haemonetics Company Information, Head Office, and Major Competitors
Table 51. Haemonetics Major Business
Table 52. Haemonetics Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
Table 53. Haemonetics Cell and Gene Therapy Supply Chain and Logistics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 54. Haemonetics Recent Developments and Future Plans
Table 55. MasterControl Company Information, Head Office, and Major Competitors
Table 56. MasterControl Major Business
Table 57. MasterControl Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
Table 58. MasterControl Cell and Gene Therapy Supply Chain and Logistics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 59. MasterControl Recent Developments and Future Plans
Table 60. TraceLink Company Information, Head Office, and Major Competitors
Table 61. TraceLink Major Business
Table 62. TraceLink Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
Table 63. TraceLink Cell and Gene Therapy Supply Chain and Logistics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 64. TraceLink Recent Developments and Future Plans
Table 65. SAVSU Technologies Company Information, Head Office, and Major Competitors
Table 66. SAVSU Technologies Major Business
Table 67. SAVSU Technologies Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
Table 68. SAVSU Technologies Cell and Gene Therapy Supply Chain and Logistics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 69. SAVSU Technologies Recent Developments and Future Plans
Table 70. TrakCel Company Information, Head Office, and Major Competitors
Table 71. TrakCel Major Business
Table 72. TrakCel Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
Table 73. TrakCel Cell and Gene Therapy Supply Chain and Logistics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 74. TrakCel Recent Developments and Future Plans
Table 75. Title21 Health Solutions Company Information, Head Office, and Major Competitors
Table 76. Title21 Health Solutions Major Business
Table 77. Title21 Health Solutions Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
Table 78. Title21 Health Solutions Cell and Gene Therapy Supply Chain and Logistics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 79. Title21 Health Solutions Recent Developments and Future Plans
Table 80. sedApta Group Company Information, Head Office, and Major Competitors
Table 81. sedApta Group Major Business
Table 82. sedApta Group Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
Table 83. sedApta Group Cell and Gene Therapy Supply Chain and Logistics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 84. sedApta Group Recent Developments and Future Plans
Table 85. Vineti Company Information, Head Office, and Major Competitors
Table 86. Vineti Major Business
Table 87. Vineti Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
Table 88. Vineti Cell and Gene Therapy Supply Chain and Logistics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 89. Vineti Recent Developments and Future Plans
Table 90. Stafa Cellular Therapy Company Information, Head Office, and Major Competitors
Table 91. Stafa Cellular Therapy Major Business
Table 92. Stafa Cellular Therapy Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
Table 93. Stafa Cellular Therapy Cell and Gene Therapy Supply Chain and Logistics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 94. Stafa Cellular Therapy Recent Developments and Future Plans
Table 95. Thermo Fisher Scientific Company Information, Head Office, and Major Competitors
Table 96. Thermo Fisher Scientific Major Business
Table 97. Thermo Fisher Scientific Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
Table 98. Thermo Fisher Scientific Cell and Gene Therapy Supply Chain and Logistics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 99. Thermo Fisher Scientific Recent Developments and Future Plans
Table 100. McKesson Company Information, Head Office, and Major Competitors
Table 101. McKesson Major Business
Table 102. McKesson Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
Table 103. McKesson Cell and Gene Therapy Supply Chain and Logistics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 104. McKesson Recent Developments and Future Plans
Table 105. BioLife Solutions Company Information, Head Office, and Major Competitors
Table 106. BioLife Solutions Major Business
Table 107. BioLife Solutions Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
Table 108. BioLife Solutions Cell and Gene Therapy Supply Chain and Logistics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 109. BioLife Solutions Recent Developments and Future Plans
Table 110. Global Cell and Gene Therapy Supply Chain and Logistics Revenue (USD Million) by Players (2019-2024)
Table 111. Global Cell and Gene Therapy Supply Chain and Logistics Revenue Share by Players (2019-2024)
Table 112. Breakdown of Cell and Gene Therapy Supply Chain and Logistics by Company Type (Tier 1, Tier 2, and Tier 3)
Table 113. Market Position of Players in Cell and Gene Therapy Supply Chain and Logistics, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 114. Head Office of Key Cell and Gene Therapy Supply Chain and Logistics Players
Table 115. Cell and Gene Therapy Supply Chain and Logistics Market: Company Product Type Footprint
Table 116. Cell and Gene Therapy Supply Chain and Logistics Market: Company Product Application Footprint
Table 117. Cell and Gene Therapy Supply Chain and Logistics New Market Entrants and Barriers to Market Entry
Table 118. Cell and Gene Therapy Supply Chain and Logistics Mergers, Acquisition, Agreements, and Collaborations
Table 119. Global Cell and Gene Therapy Supply Chain and Logistics Consumption Value (USD Million) by Type (2019-2024)
Table 120. Global Cell and Gene Therapy Supply Chain and Logistics Consumption Value Share by Type (2019-2024)
Table 121. Global Cell and Gene Therapy Supply Chain and Logistics Consumption Value Forecast by Type (2025-2030)
Table 122. Global Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Application (2019-2024)
Table 123. Global Cell and Gene Therapy Supply Chain and Logistics Consumption Value Forecast by Application (2025-2030)
Table 124. North America Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Type (2019-2024) & (USD Million)
Table 125. North America Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Type (2025-2030) & (USD Million)
Table 126. North America Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Application (2019-2024) & (USD Million)
Table 127. North America Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Application (2025-2030) & (USD Million)
Table 128. North America Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Country (2019-2024) & (USD Million)
Table 129. North America Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Country (2025-2030) & (USD Million)
Table 130. Europe Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Type (2019-2024) & (USD Million)
Table 131. Europe Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Type (2025-2030) & (USD Million)
Table 132. Europe Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Application (2019-2024) & (USD Million)
Table 133. Europe Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Application (2025-2030) & (USD Million)
Table 134. Europe Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Country (2019-2024) & (USD Million)
Table 135. Europe Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Country (2025-2030) & (USD Million)
Table 136. Asia-Pacific Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Type (2019-2024) & (USD Million)
Table 137. Asia-Pacific Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Type (2025-2030) & (USD Million)
Table 138. Asia-Pacific Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Application (2019-2024) & (USD Million)
Table 139. Asia-Pacific Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Application (2025-2030) & (USD Million)
Table 140. Asia-Pacific Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Region (2019-2024) & (USD Million)
Table 141. Asia-Pacific Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Region (2025-2030) & (USD Million)
Table 142. South America Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Type (2019-2024) & (USD Million)
Table 143. South America Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Type (2025-2030) & (USD Million)
Table 144. South America Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Application (2019-2024) & (USD Million)
Table 145. South America Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Application (2025-2030) & (USD Million)
Table 146. South America Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Country (2019-2024) & (USD Million)
Table 147. South America Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Country (2025-2030) & (USD Million)
Table 148. Middle East & Africa Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Type (2019-2024) & (USD Million)
Table 149. Middle East & Africa Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Type (2025-2030) & (USD Million)
Table 150. Middle East & Africa Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Application (2019-2024) & (USD Million)
Table 151. Middle East & Africa Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Application (2025-2030) & (USD Million)
Table 152. Middle East & Africa Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Country (2019-2024) & (USD Million)
Table 153. Middle East & Africa Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Country (2025-2030) & (USD Million)
Table 154. Cell and Gene Therapy Supply Chain and Logistics Raw Material
Table 155. Key Suppliers of Cell and Gene Therapy Supply Chain and Logistics Raw Materials
List of Figures
Figure 1. Cell and Gene Therapy Supply Chain and Logistics Picture
Figure 2. Global Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Cell and Gene Therapy Supply Chain and Logistics Consumption Value Market Share by Type in 2023
Figure 4. Ordering and Scheduling Services
Figure 5. Sample Collection Services
Figure 6. Logistics Services
Figure 7. Post Treatment Follow-Up Services
Figure 8. Global Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 9. Cell and Gene Therapy Supply Chain and Logistics Consumption Value Market Share by Application in 2023
Figure 10. Biobank Picture
Figure 11. Cell Therapy Lab Picture
Figure 12. Hospital Picture
Figure 13. Research Institute Picture
Figure 14. Global Cell and Gene Therapy Supply Chain and Logistics Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 15. Global Cell and Gene Therapy Supply Chain and Logistics Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 16. Global Market Cell and Gene Therapy Supply Chain and Logistics Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 17. Global Cell and Gene Therapy Supply Chain and Logistics Consumption Value Market Share by Region (2019-2030)
Figure 18. Global Cell and Gene Therapy Supply Chain and Logistics Consumption Value Market Share by Region in 2023
Figure 19. North America Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2019-2030) & (USD Million)
Figure 20. Europe Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2019-2030) & (USD Million)
Figure 21. Asia-Pacific Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2019-2030) & (USD Million)
Figure 22. South America Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2019-2030) & (USD Million)
Figure 23. Middle East and Africa Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2019-2030) & (USD Million)
Figure 24. Global Cell and Gene Therapy Supply Chain and Logistics Revenue Share by Players in 2023
Figure 25. Cell and Gene Therapy Supply Chain and Logistics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 26. Global Top 3 Players Cell and Gene Therapy Supply Chain and Logistics Market Share in 2023
Figure 27. Global Top 6 Players Cell and Gene Therapy Supply Chain and Logistics Market Share in 2023
Figure 28. Global Cell and Gene Therapy Supply Chain and Logistics Consumption Value Share by Type (2019-2024)
Figure 29. Global Cell and Gene Therapy Supply Chain and Logistics Market Share Forecast by Type (2025-2030)
Figure 30. Global Cell and Gene Therapy Supply Chain and Logistics Consumption Value Share by Application (2019-2024)
Figure 31. Global Cell and Gene Therapy Supply Chain and Logistics Market Share Forecast by Application (2025-2030)
Figure 32. North America Cell and Gene Therapy Supply Chain and Logistics Consumption Value Market Share by Type (2019-2030)
Figure 33. North America Cell and Gene Therapy Supply Chain and Logistics Consumption Value Market Share by Application (2019-2030)
Figure 34. North America Cell and Gene Therapy Supply Chain and Logistics Consumption Value Market Share by Country (2019-2030)
Figure 35. United States Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2019-2030) & (USD Million)
Figure 36. Canada Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2019-2030) & (USD Million)
Figure 37. Mexico Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2019-2030) & (USD Million)
Figure 38. Europe Cell and Gene Therapy Supply Chain and Logistics Consumption Value Market Share by Type (2019-2030)
Figure 39. Europe Cell and Gene Therapy Supply Chain and Logistics Consumption Value Market Share by Application (2019-2030)
Figure 40. Europe Cell and Gene Therapy Supply Chain and Logistics Consumption Value Market Share by Country (2019-2030)
Figure 41. Germany Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2019-2030) & (USD Million)
Figure 42. France Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2019-2030) & (USD Million)
Figure 43. United Kingdom Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2019-2030) & (USD Million)
Figure 44. Russia Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2019-2030) & (USD Million)
Figure 45. Italy Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2019-2030) & (USD Million)
Figure 46. Asia-Pacific Cell and Gene Therapy Supply Chain and Logistics Consumption Value Market Share by Type (2019-2030)
Figure 47. Asia-Pacific Cell and Gene Therapy Supply Chain and Logistics Consumption Value Market Share by Application (2019-2030)
Figure 48. Asia-Pacific Cell and Gene Therapy Supply Chain and Logistics Consumption Value Market Share by Region (2019-2030)
Figure 49. China Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2019-2030) & (USD Million)
Figure 50. Japan Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2019-2030) & (USD Million)
Figure 51. South Korea Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2019-2030) & (USD Million)
Figure 52. India Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2019-2030) & (USD Million)
Figure 53. Southeast Asia Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2019-2030) & (USD Million)
Figure 54. Australia Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2019-2030) & (USD Million)
Figure 55. South America Cell and Gene Therapy Supply Chain and Logistics Consumption Value Market Share by Type (2019-2030)
Figure 56. South America Cell and Gene Therapy Supply Chain and Logistics Consumption Value Market Share by Application (2019-2030)
Figure 57. South America Cell and Gene Therapy Supply Chain and Logistics Consumption Value Market Share by Country (2019-2030)
Figure 58. Brazil Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2019-2030) & (USD Million)
Figure 59. Argentina Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2019-2030) & (USD Million)
Figure 60. Middle East and Africa Cell and Gene Therapy Supply Chain and Logistics Consumption Value Market Share by Type (2019-2030)
Figure 61. Middle East and Africa Cell and Gene Therapy Supply Chain and Logistics Consumption Value Market Share by Application (2019-2030)
Figure 62. Middle East and Africa Cell and Gene Therapy Supply Chain and Logistics Consumption Value Market Share by Country (2019-2030)
Figure 63. Turkey Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2019-2030) & (USD Million)
Figure 64. Saudi Arabia Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2019-2030) & (USD Million)
Figure 65. UAE Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2019-2030) & (USD Million)
Figure 66. Cell and Gene Therapy Supply Chain and Logistics Market Drivers
Figure 67. Cell and Gene Therapy Supply Chain and Logistics Market Restraints
Figure 68. Cell and Gene Therapy Supply Chain and Logistics Market Trends
Figure 69. Porters Five Forces Analysis
Figure 70. Manufacturing Cost Structure Analysis of Cell and Gene Therapy Supply Chain and Logistics in 2023
Figure 71. Manufacturing Process Analysis of Cell and Gene Therapy Supply Chain and Logistics
Figure 72. Cell and Gene Therapy Supply Chain and Logistics Industrial Chain
Figure 73. Methodology
Figure 74. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

btl

Companies Mentioned

Be The Match BioTherapies
Biocair
Marken
World Courier
MAK-SYSTEM
Cryoport
Brooks Life Sciences
Clarkston Consulting
Hypertrust Patient Data Care
Haemonetics
MasterControl
TraceLink
SAVSU Technologies
TrakCel
Title21 Health Solutions
sedApta Group
Vineti
Stafa Cellular Therapy
Thermo Fisher Scientific
McKesson
BioLife Solutions
shop_t

Purchase Options

jiaGou

Add To Cart

jiaGou

Buy Now

masterCard
visa
jcb
americanExpress
shop_b
Global Cell and Gene Therapy Supply Chain and Logistics Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global Cell and Gene Therapy Supply Chain and Logistics Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Page: 142

Published Date: 29 Jan 2024

Category: Service & Software

PDF Download

Get FREE Sample

Customize Request

Description

arrow-d3
btl

Description

According to our (Global Info Research) latest study, the global Cell and Gene Therapy Supply Chain and Logistics market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

Cell and Gene Therapy Supply Chain and Logistics refer to the specialized processes and systems involved in managing the transportation, storage, and distribution of cell and gene therapy products. These therapies are often temperature-sensitive and require precise handling and monitoring.

Cell and Gene Therapy Supply Chain and Logistics: With the rapid growth of cell and gene therapy development, there is a heightened focus on building robust and secure supply chains. Trends include the use of advanced tracking and monitoring technologies, cold chain logistics, and specialized packaging to ensure the safe and efficient delivery of these therapies to patients.

The Global Info Research report includes an overview of the development of the Cell and Gene Therapy Supply Chain and Logistics industry chain, the market status of Biobank (Ordering and Scheduling Services, Sample Collection Services), Cell Therapy Lab (Ordering and Scheduling Services, Sample Collection Services), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Cell and Gene Therapy Supply Chain and Logistics.

Regionally, the report analyzes the Cell and Gene Therapy Supply Chain and Logistics markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Cell and Gene Therapy Supply Chain and Logistics market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:
The report presents comprehensive understanding of the Cell and Gene Therapy Supply Chain and Logistics market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Cell and Gene Therapy Supply Chain and Logistics industry.

The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Ordering and Scheduling Services, Sample Collection Services).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Cell and Gene Therapy Supply Chain and Logistics market.

Regional Analysis: The report involves examining the Cell and Gene Therapy Supply Chain and Logistics market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Cell and Gene Therapy Supply Chain and Logistics market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to Cell and Gene Therapy Supply Chain and Logistics:
Company Analysis: Report covers individual Cell and Gene Therapy Supply Chain and Logistics players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Cell and Gene Therapy Supply Chain and Logistics This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Biobank, Cell Therapy Lab).

Technology Analysis: Report covers specific technologies relevant to Cell and Gene Therapy Supply Chain and Logistics. It assesses the current state, advancements, and potential future developments in Cell and Gene Therapy Supply Chain and Logistics areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Cell and Gene Therapy Supply Chain and Logistics market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation
Cell and Gene Therapy Supply Chain and Logistics market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.

Market segment by Type
Ordering and Scheduling Services
Sample Collection Services
Logistics Services
Post Treatment Follow-Up Services

Market segment by Application
Biobank
Cell Therapy Lab
Hospital
Research Institute

Market segment by players, this report covers
Be The Match BioTherapies
Biocair
Marken
World Courier
MAK-SYSTEM
Cryoport
Brooks Life Sciences
Clarkston Consulting
Hypertrust Patient Data Care
Haemonetics
MasterControl
TraceLink
SAVSU Technologies
TrakCel
Title21 Health Solutions
sedApta Group
Vineti
Stafa Cellular Therapy
Thermo Fisher Scientific
McKesson
BioLife Solutions

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Cell and Gene Therapy Supply Chain and Logistics product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Cell and Gene Therapy Supply Chain and Logistics, with revenue, gross margin and global market share of Cell and Gene Therapy Supply Chain and Logistics from 2019 to 2024.
Chapter 3, the Cell and Gene Therapy Supply Chain and Logistics competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Cell and Gene Therapy Supply Chain and Logistics market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Cell and Gene Therapy Supply Chain and Logistics.
Chapter 13, to describe Cell and Gene Therapy Supply Chain and Logistics research findings and conclusion.
btl

Table of Contents

1 Market Overview
1.1 Product Overview and Scope of Cell and Gene Therapy Supply Chain and Logistics
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Cell and Gene Therapy Supply Chain and Logistics by Type
1.3.1 Overview: Global Cell and Gene Therapy Supply Chain and Logistics Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Cell and Gene Therapy Supply Chain and Logistics Consumption Value Market Share by Type in 2023
1.3.3 Ordering and Scheduling Services
1.3.4 Sample Collection Services
1.3.5 Logistics Services
1.3.6 Post Treatment Follow-Up Services
1.4 Global Cell and Gene Therapy Supply Chain and Logistics Market by Application
1.4.1 Overview: Global Cell and Gene Therapy Supply Chain and Logistics Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Biobank
1.4.3 Cell Therapy Lab
1.4.4 Hospital
1.4.5 Research Institute
1.5 Global Cell and Gene Therapy Supply Chain and Logistics Market Size & Forecast
1.6 Global Cell and Gene Therapy Supply Chain and Logistics Market Size and Forecast by Region
1.6.1 Global Cell and Gene Therapy Supply Chain and Logistics Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Cell and Gene Therapy Supply Chain and Logistics Market Size by Region, (2019-2030)
1.6.3 North America Cell and Gene Therapy Supply Chain and Logistics Market Size and Prospect (2019-2030)
1.6.4 Europe Cell and Gene Therapy Supply Chain and Logistics Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Cell and Gene Therapy Supply Chain and Logistics Market Size and Prospect (2019-2030)
1.6.6 South America Cell and Gene Therapy Supply Chain and Logistics Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Cell and Gene Therapy Supply Chain and Logistics Market Size and Prospect (2019-2030)

2 Company Profiles
2.1 Be The Match BioTherapies
2.1.1 Be The Match BioTherapies Details
2.1.2 Be The Match BioTherapies Major Business
2.1.3 Be The Match BioTherapies Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
2.1.4 Be The Match BioTherapies Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Be The Match BioTherapies Recent Developments and Future Plans
2.2 Biocair
2.2.1 Biocair Details
2.2.2 Biocair Major Business
2.2.3 Biocair Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
2.2.4 Biocair Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Biocair Recent Developments and Future Plans
2.3 Marken
2.3.1 Marken Details
2.3.2 Marken Major Business
2.3.3 Marken Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
2.3.4 Marken Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Marken Recent Developments and Future Plans
2.4 World Courier
2.4.1 World Courier Details
2.4.2 World Courier Major Business
2.4.3 World Courier Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
2.4.4 World Courier Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 World Courier Recent Developments and Future Plans
2.5 MAK-SYSTEM
2.5.1 MAK-SYSTEM Details
2.5.2 MAK-SYSTEM Major Business
2.5.3 MAK-SYSTEM Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
2.5.4 MAK-SYSTEM Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 MAK-SYSTEM Recent Developments and Future Plans
2.6 Cryoport
2.6.1 Cryoport Details
2.6.2 Cryoport Major Business
2.6.3 Cryoport Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
2.6.4 Cryoport Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Cryoport Recent Developments and Future Plans
2.7 Brooks Life Sciences
2.7.1 Brooks Life Sciences Details
2.7.2 Brooks Life Sciences Major Business
2.7.3 Brooks Life Sciences Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
2.7.4 Brooks Life Sciences Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Brooks Life Sciences Recent Developments and Future Plans
2.8 Clarkston Consulting
2.8.1 Clarkston Consulting Details
2.8.2 Clarkston Consulting Major Business
2.8.3 Clarkston Consulting Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
2.8.4 Clarkston Consulting Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Clarkston Consulting Recent Developments and Future Plans
2.9 Hypertrust Patient Data Care
2.9.1 Hypertrust Patient Data Care Details
2.9.2 Hypertrust Patient Data Care Major Business
2.9.3 Hypertrust Patient Data Care Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
2.9.4 Hypertrust Patient Data Care Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Hypertrust Patient Data Care Recent Developments and Future Plans
2.10 Haemonetics
2.10.1 Haemonetics Details
2.10.2 Haemonetics Major Business
2.10.3 Haemonetics Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
2.10.4 Haemonetics Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Haemonetics Recent Developments and Future Plans
2.11 MasterControl
2.11.1 MasterControl Details
2.11.2 MasterControl Major Business
2.11.3 MasterControl Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
2.11.4 MasterControl Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 MasterControl Recent Developments and Future Plans
2.12 TraceLink
2.12.1 TraceLink Details
2.12.2 TraceLink Major Business
2.12.3 TraceLink Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
2.12.4 TraceLink Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 TraceLink Recent Developments and Future Plans
2.13 SAVSU Technologies
2.13.1 SAVSU Technologies Details
2.13.2 SAVSU Technologies Major Business
2.13.3 SAVSU Technologies Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
2.13.4 SAVSU Technologies Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 SAVSU Technologies Recent Developments and Future Plans
2.14 TrakCel
2.14.1 TrakCel Details
2.14.2 TrakCel Major Business
2.14.3 TrakCel Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
2.14.4 TrakCel Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2019-2024)
2.14.5 TrakCel Recent Developments and Future Plans
2.15 Title21 Health Solutions
2.15.1 Title21 Health Solutions Details
2.15.2 Title21 Health Solutions Major Business
2.15.3 Title21 Health Solutions Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
2.15.4 Title21 Health Solutions Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2019-2024)
2.15.5 Title21 Health Solutions Recent Developments and Future Plans
2.16 sedApta Group
2.16.1 sedApta Group Details
2.16.2 sedApta Group Major Business
2.16.3 sedApta Group Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
2.16.4 sedApta Group Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2019-2024)
2.16.5 sedApta Group Recent Developments and Future Plans
2.17 Vineti
2.17.1 Vineti Details
2.17.2 Vineti Major Business
2.17.3 Vineti Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
2.17.4 Vineti Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2019-2024)
2.17.5 Vineti Recent Developments and Future Plans
2.18 Stafa Cellular Therapy
2.18.1 Stafa Cellular Therapy Details
2.18.2 Stafa Cellular Therapy Major Business
2.18.3 Stafa Cellular Therapy Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
2.18.4 Stafa Cellular Therapy Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2019-2024)
2.18.5 Stafa Cellular Therapy Recent Developments and Future Plans
2.19 Thermo Fisher Scientific
2.19.1 Thermo Fisher Scientific Details
2.19.2 Thermo Fisher Scientific Major Business
2.19.3 Thermo Fisher Scientific Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
2.19.4 Thermo Fisher Scientific Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2019-2024)
2.19.5 Thermo Fisher Scientific Recent Developments and Future Plans
2.20 McKesson
2.20.1 McKesson Details
2.20.2 McKesson Major Business
2.20.3 McKesson Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
2.20.4 McKesson Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2019-2024)
2.20.5 McKesson Recent Developments and Future Plans
2.21 BioLife Solutions
2.21.1 BioLife Solutions Details
2.21.2 BioLife Solutions Major Business
2.21.3 BioLife Solutions Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
2.21.4 BioLife Solutions Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2019-2024)
2.21.5 BioLife Solutions Recent Developments and Future Plans

3 Market Competition, by Players
3.1 Global Cell and Gene Therapy Supply Chain and Logistics Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Cell and Gene Therapy Supply Chain and Logistics by Company Revenue
3.2.2 Top 3 Cell and Gene Therapy Supply Chain and Logistics Players Market Share in 2023
3.2.3 Top 6 Cell and Gene Therapy Supply Chain and Logistics Players Market Share in 2023
3.3 Cell and Gene Therapy Supply Chain and Logistics Market: Overall Company Footprint Analysis
3.3.1 Cell and Gene Therapy Supply Chain and Logistics Market: Region Footprint
3.3.2 Cell and Gene Therapy Supply Chain and Logistics Market: Company Product Type Footprint
3.3.3 Cell and Gene Therapy Supply Chain and Logistics Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type
4.1 Global Cell and Gene Therapy Supply Chain and Logistics Consumption Value and Market Share by Type (2019-2024)
4.2 Global Cell and Gene Therapy Supply Chain and Logistics Market Forecast by Type (2025-2030)

5 Market Size Segment by Application
5.1 Global Cell and Gene Therapy Supply Chain and Logistics Consumption Value Market Share by Application (2019-2024)
5.2 Global Cell and Gene Therapy Supply Chain and Logistics Market Forecast by Application (2025-2030)

6 North America
6.1 North America Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Type (2019-2030)
6.2 North America Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Application (2019-2030)
6.3 North America Cell and Gene Therapy Supply Chain and Logistics Market Size by Country
6.3.1 North America Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Country (2019-2030)
6.3.2 United States Cell and Gene Therapy Supply Chain and Logistics Market Size and Forecast (2019-2030)
6.3.3 Canada Cell and Gene Therapy Supply Chain and Logistics Market Size and Forecast (2019-2030)
6.3.4 Mexico Cell and Gene Therapy Supply Chain and Logistics Market Size and Forecast (2019-2030)

7 Europe
7.1 Europe Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Type (2019-2030)
7.2 Europe Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Application (2019-2030)
7.3 Europe Cell and Gene Therapy Supply Chain and Logistics Market Size by Country
7.3.1 Europe Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Country (2019-2030)
7.3.2 Germany Cell and Gene Therapy Supply Chain and Logistics Market Size and Forecast (2019-2030)
7.3.3 France Cell and Gene Therapy Supply Chain and Logistics Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Cell and Gene Therapy Supply Chain and Logistics Market Size and Forecast (2019-2030)
7.3.5 Russia Cell and Gene Therapy Supply Chain and Logistics Market Size and Forecast (2019-2030)
7.3.6 Italy Cell and Gene Therapy Supply Chain and Logistics Market Size and Forecast (2019-2030)

8 Asia-Pacific
8.1 Asia-Pacific Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Cell and Gene Therapy Supply Chain and Logistics Market Size by Region
8.3.1 Asia-Pacific Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Region (2019-2030)
8.3.2 China Cell and Gene Therapy Supply Chain and Logistics Market Size and Forecast (2019-2030)
8.3.3 Japan Cell and Gene Therapy Supply Chain and Logistics Market Size and Forecast (2019-2030)
8.3.4 South Korea Cell and Gene Therapy Supply Chain and Logistics Market Size and Forecast (2019-2030)
8.3.5 India Cell and Gene Therapy Supply Chain and Logistics Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Cell and Gene Therapy Supply Chain and Logistics Market Size and Forecast (2019-2030)
8.3.7 Australia Cell and Gene Therapy Supply Chain and Logistics Market Size and Forecast (2019-2030)

9 South America
9.1 South America Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Type (2019-2030)
9.2 South America Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Application (2019-2030)
9.3 South America Cell and Gene Therapy Supply Chain and Logistics Market Size by Country
9.3.1 South America Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Country (2019-2030)
9.3.2 Brazil Cell and Gene Therapy Supply Chain and Logistics Market Size and Forecast (2019-2030)
9.3.3 Argentina Cell and Gene Therapy Supply Chain and Logistics Market Size and Forecast (2019-2030)

10 Middle East & Africa
10.1 Middle East & Africa Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Cell and Gene Therapy Supply Chain and Logistics Market Size by Country
10.3.1 Middle East & Africa Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Country (2019-2030)
10.3.2 Turkey Cell and Gene Therapy Supply Chain and Logistics Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Cell and Gene Therapy Supply Chain and Logistics Market Size and Forecast (2019-2030)
10.3.4 UAE Cell and Gene Therapy Supply Chain and Logistics Market Size and Forecast (2019-2030)

11 Market Dynamics
11.1 Cell and Gene Therapy Supply Chain and Logistics Market Drivers
11.2 Cell and Gene Therapy Supply Chain and Logistics Market Restraints
11.3 Cell and Gene Therapy Supply Chain and Logistics Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry

12 Industry Chain Analysis
12.1 Cell and Gene Therapy Supply Chain and Logistics Industry Chain
12.2 Cell and Gene Therapy Supply Chain and Logistics Upstream Analysis
12.3 Cell and Gene Therapy Supply Chain and Logistics Midstream Analysis
12.4 Cell and Gene Therapy Supply Chain and Logistics Downstream Analysis

13 Research Findings and Conclusion

14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. Global Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Region (2025-2030) & (USD Million)
Table 5. Be The Match BioTherapies Company Information, Head Office, and Major Competitors
Table 6. Be The Match BioTherapies Major Business
Table 7. Be The Match BioTherapies Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
Table 8. Be The Match BioTherapies Cell and Gene Therapy Supply Chain and Logistics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. Be The Match BioTherapies Recent Developments and Future Plans
Table 10. Biocair Company Information, Head Office, and Major Competitors
Table 11. Biocair Major Business
Table 12. Biocair Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
Table 13. Biocair Cell and Gene Therapy Supply Chain and Logistics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. Biocair Recent Developments and Future Plans
Table 15. Marken Company Information, Head Office, and Major Competitors
Table 16. Marken Major Business
Table 17. Marken Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
Table 18. Marken Cell and Gene Therapy Supply Chain and Logistics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. Marken Recent Developments and Future Plans
Table 20. World Courier Company Information, Head Office, and Major Competitors
Table 21. World Courier Major Business
Table 22. World Courier Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
Table 23. World Courier Cell and Gene Therapy Supply Chain and Logistics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. World Courier Recent Developments and Future Plans
Table 25. MAK-SYSTEM Company Information, Head Office, and Major Competitors
Table 26. MAK-SYSTEM Major Business
Table 27. MAK-SYSTEM Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
Table 28. MAK-SYSTEM Cell and Gene Therapy Supply Chain and Logistics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. MAK-SYSTEM Recent Developments and Future Plans
Table 30. Cryoport Company Information, Head Office, and Major Competitors
Table 31. Cryoport Major Business
Table 32. Cryoport Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
Table 33. Cryoport Cell and Gene Therapy Supply Chain and Logistics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. Cryoport Recent Developments and Future Plans
Table 35. Brooks Life Sciences Company Information, Head Office, and Major Competitors
Table 36. Brooks Life Sciences Major Business
Table 37. Brooks Life Sciences Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
Table 38. Brooks Life Sciences Cell and Gene Therapy Supply Chain and Logistics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 39. Brooks Life Sciences Recent Developments and Future Plans
Table 40. Clarkston Consulting Company Information, Head Office, and Major Competitors
Table 41. Clarkston Consulting Major Business
Table 42. Clarkston Consulting Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
Table 43. Clarkston Consulting Cell and Gene Therapy Supply Chain and Logistics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 44. Clarkston Consulting Recent Developments and Future Plans
Table 45. Hypertrust Patient Data Care Company Information, Head Office, and Major Competitors
Table 46. Hypertrust Patient Data Care Major Business
Table 47. Hypertrust Patient Data Care Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
Table 48. Hypertrust Patient Data Care Cell and Gene Therapy Supply Chain and Logistics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 49. Hypertrust Patient Data Care Recent Developments and Future Plans
Table 50. Haemonetics Company Information, Head Office, and Major Competitors
Table 51. Haemonetics Major Business
Table 52. Haemonetics Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
Table 53. Haemonetics Cell and Gene Therapy Supply Chain and Logistics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 54. Haemonetics Recent Developments and Future Plans
Table 55. MasterControl Company Information, Head Office, and Major Competitors
Table 56. MasterControl Major Business
Table 57. MasterControl Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
Table 58. MasterControl Cell and Gene Therapy Supply Chain and Logistics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 59. MasterControl Recent Developments and Future Plans
Table 60. TraceLink Company Information, Head Office, and Major Competitors
Table 61. TraceLink Major Business
Table 62. TraceLink Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
Table 63. TraceLink Cell and Gene Therapy Supply Chain and Logistics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 64. TraceLink Recent Developments and Future Plans
Table 65. SAVSU Technologies Company Information, Head Office, and Major Competitors
Table 66. SAVSU Technologies Major Business
Table 67. SAVSU Technologies Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
Table 68. SAVSU Technologies Cell and Gene Therapy Supply Chain and Logistics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 69. SAVSU Technologies Recent Developments and Future Plans
Table 70. TrakCel Company Information, Head Office, and Major Competitors
Table 71. TrakCel Major Business
Table 72. TrakCel Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
Table 73. TrakCel Cell and Gene Therapy Supply Chain and Logistics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 74. TrakCel Recent Developments and Future Plans
Table 75. Title21 Health Solutions Company Information, Head Office, and Major Competitors
Table 76. Title21 Health Solutions Major Business
Table 77. Title21 Health Solutions Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
Table 78. Title21 Health Solutions Cell and Gene Therapy Supply Chain and Logistics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 79. Title21 Health Solutions Recent Developments and Future Plans
Table 80. sedApta Group Company Information, Head Office, and Major Competitors
Table 81. sedApta Group Major Business
Table 82. sedApta Group Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
Table 83. sedApta Group Cell and Gene Therapy Supply Chain and Logistics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 84. sedApta Group Recent Developments and Future Plans
Table 85. Vineti Company Information, Head Office, and Major Competitors
Table 86. Vineti Major Business
Table 87. Vineti Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
Table 88. Vineti Cell and Gene Therapy Supply Chain and Logistics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 89. Vineti Recent Developments and Future Plans
Table 90. Stafa Cellular Therapy Company Information, Head Office, and Major Competitors
Table 91. Stafa Cellular Therapy Major Business
Table 92. Stafa Cellular Therapy Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
Table 93. Stafa Cellular Therapy Cell and Gene Therapy Supply Chain and Logistics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 94. Stafa Cellular Therapy Recent Developments and Future Plans
Table 95. Thermo Fisher Scientific Company Information, Head Office, and Major Competitors
Table 96. Thermo Fisher Scientific Major Business
Table 97. Thermo Fisher Scientific Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
Table 98. Thermo Fisher Scientific Cell and Gene Therapy Supply Chain and Logistics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 99. Thermo Fisher Scientific Recent Developments and Future Plans
Table 100. McKesson Company Information, Head Office, and Major Competitors
Table 101. McKesson Major Business
Table 102. McKesson Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
Table 103. McKesson Cell and Gene Therapy Supply Chain and Logistics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 104. McKesson Recent Developments and Future Plans
Table 105. BioLife Solutions Company Information, Head Office, and Major Competitors
Table 106. BioLife Solutions Major Business
Table 107. BioLife Solutions Cell and Gene Therapy Supply Chain and Logistics Product and Solutions
Table 108. BioLife Solutions Cell and Gene Therapy Supply Chain and Logistics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 109. BioLife Solutions Recent Developments and Future Plans
Table 110. Global Cell and Gene Therapy Supply Chain and Logistics Revenue (USD Million) by Players (2019-2024)
Table 111. Global Cell and Gene Therapy Supply Chain and Logistics Revenue Share by Players (2019-2024)
Table 112. Breakdown of Cell and Gene Therapy Supply Chain and Logistics by Company Type (Tier 1, Tier 2, and Tier 3)
Table 113. Market Position of Players in Cell and Gene Therapy Supply Chain and Logistics, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 114. Head Office of Key Cell and Gene Therapy Supply Chain and Logistics Players
Table 115. Cell and Gene Therapy Supply Chain and Logistics Market: Company Product Type Footprint
Table 116. Cell and Gene Therapy Supply Chain and Logistics Market: Company Product Application Footprint
Table 117. Cell and Gene Therapy Supply Chain and Logistics New Market Entrants and Barriers to Market Entry
Table 118. Cell and Gene Therapy Supply Chain and Logistics Mergers, Acquisition, Agreements, and Collaborations
Table 119. Global Cell and Gene Therapy Supply Chain and Logistics Consumption Value (USD Million) by Type (2019-2024)
Table 120. Global Cell and Gene Therapy Supply Chain and Logistics Consumption Value Share by Type (2019-2024)
Table 121. Global Cell and Gene Therapy Supply Chain and Logistics Consumption Value Forecast by Type (2025-2030)
Table 122. Global Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Application (2019-2024)
Table 123. Global Cell and Gene Therapy Supply Chain and Logistics Consumption Value Forecast by Application (2025-2030)
Table 124. North America Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Type (2019-2024) & (USD Million)
Table 125. North America Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Type (2025-2030) & (USD Million)
Table 126. North America Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Application (2019-2024) & (USD Million)
Table 127. North America Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Application (2025-2030) & (USD Million)
Table 128. North America Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Country (2019-2024) & (USD Million)
Table 129. North America Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Country (2025-2030) & (USD Million)
Table 130. Europe Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Type (2019-2024) & (USD Million)
Table 131. Europe Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Type (2025-2030) & (USD Million)
Table 132. Europe Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Application (2019-2024) & (USD Million)
Table 133. Europe Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Application (2025-2030) & (USD Million)
Table 134. Europe Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Country (2019-2024) & (USD Million)
Table 135. Europe Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Country (2025-2030) & (USD Million)
Table 136. Asia-Pacific Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Type (2019-2024) & (USD Million)
Table 137. Asia-Pacific Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Type (2025-2030) & (USD Million)
Table 138. Asia-Pacific Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Application (2019-2024) & (USD Million)
Table 139. Asia-Pacific Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Application (2025-2030) & (USD Million)
Table 140. Asia-Pacific Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Region (2019-2024) & (USD Million)
Table 141. Asia-Pacific Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Region (2025-2030) & (USD Million)
Table 142. South America Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Type (2019-2024) & (USD Million)
Table 143. South America Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Type (2025-2030) & (USD Million)
Table 144. South America Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Application (2019-2024) & (USD Million)
Table 145. South America Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Application (2025-2030) & (USD Million)
Table 146. South America Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Country (2019-2024) & (USD Million)
Table 147. South America Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Country (2025-2030) & (USD Million)
Table 148. Middle East & Africa Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Type (2019-2024) & (USD Million)
Table 149. Middle East & Africa Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Type (2025-2030) & (USD Million)
Table 150. Middle East & Africa Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Application (2019-2024) & (USD Million)
Table 151. Middle East & Africa Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Application (2025-2030) & (USD Million)
Table 152. Middle East & Africa Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Country (2019-2024) & (USD Million)
Table 153. Middle East & Africa Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Country (2025-2030) & (USD Million)
Table 154. Cell and Gene Therapy Supply Chain and Logistics Raw Material
Table 155. Key Suppliers of Cell and Gene Therapy Supply Chain and Logistics Raw Materials
List of Figures
Figure 1. Cell and Gene Therapy Supply Chain and Logistics Picture
Figure 2. Global Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Cell and Gene Therapy Supply Chain and Logistics Consumption Value Market Share by Type in 2023
Figure 4. Ordering and Scheduling Services
Figure 5. Sample Collection Services
Figure 6. Logistics Services
Figure 7. Post Treatment Follow-Up Services
Figure 8. Global Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 9. Cell and Gene Therapy Supply Chain and Logistics Consumption Value Market Share by Application in 2023
Figure 10. Biobank Picture
Figure 11. Cell Therapy Lab Picture
Figure 12. Hospital Picture
Figure 13. Research Institute Picture
Figure 14. Global Cell and Gene Therapy Supply Chain and Logistics Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 15. Global Cell and Gene Therapy Supply Chain and Logistics Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 16. Global Market Cell and Gene Therapy Supply Chain and Logistics Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 17. Global Cell and Gene Therapy Supply Chain and Logistics Consumption Value Market Share by Region (2019-2030)
Figure 18. Global Cell and Gene Therapy Supply Chain and Logistics Consumption Value Market Share by Region in 2023
Figure 19. North America Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2019-2030) & (USD Million)
Figure 20. Europe Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2019-2030) & (USD Million)
Figure 21. Asia-Pacific Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2019-2030) & (USD Million)
Figure 22. South America Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2019-2030) & (USD Million)
Figure 23. Middle East and Africa Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2019-2030) & (USD Million)
Figure 24. Global Cell and Gene Therapy Supply Chain and Logistics Revenue Share by Players in 2023
Figure 25. Cell and Gene Therapy Supply Chain and Logistics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 26. Global Top 3 Players Cell and Gene Therapy Supply Chain and Logistics Market Share in 2023
Figure 27. Global Top 6 Players Cell and Gene Therapy Supply Chain and Logistics Market Share in 2023
Figure 28. Global Cell and Gene Therapy Supply Chain and Logistics Consumption Value Share by Type (2019-2024)
Figure 29. Global Cell and Gene Therapy Supply Chain and Logistics Market Share Forecast by Type (2025-2030)
Figure 30. Global Cell and Gene Therapy Supply Chain and Logistics Consumption Value Share by Application (2019-2024)
Figure 31. Global Cell and Gene Therapy Supply Chain and Logistics Market Share Forecast by Application (2025-2030)
Figure 32. North America Cell and Gene Therapy Supply Chain and Logistics Consumption Value Market Share by Type (2019-2030)
Figure 33. North America Cell and Gene Therapy Supply Chain and Logistics Consumption Value Market Share by Application (2019-2030)
Figure 34. North America Cell and Gene Therapy Supply Chain and Logistics Consumption Value Market Share by Country (2019-2030)
Figure 35. United States Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2019-2030) & (USD Million)
Figure 36. Canada Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2019-2030) & (USD Million)
Figure 37. Mexico Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2019-2030) & (USD Million)
Figure 38. Europe Cell and Gene Therapy Supply Chain and Logistics Consumption Value Market Share by Type (2019-2030)
Figure 39. Europe Cell and Gene Therapy Supply Chain and Logistics Consumption Value Market Share by Application (2019-2030)
Figure 40. Europe Cell and Gene Therapy Supply Chain and Logistics Consumption Value Market Share by Country (2019-2030)
Figure 41. Germany Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2019-2030) & (USD Million)
Figure 42. France Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2019-2030) & (USD Million)
Figure 43. United Kingdom Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2019-2030) & (USD Million)
Figure 44. Russia Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2019-2030) & (USD Million)
Figure 45. Italy Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2019-2030) & (USD Million)
Figure 46. Asia-Pacific Cell and Gene Therapy Supply Chain and Logistics Consumption Value Market Share by Type (2019-2030)
Figure 47. Asia-Pacific Cell and Gene Therapy Supply Chain and Logistics Consumption Value Market Share by Application (2019-2030)
Figure 48. Asia-Pacific Cell and Gene Therapy Supply Chain and Logistics Consumption Value Market Share by Region (2019-2030)
Figure 49. China Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2019-2030) & (USD Million)
Figure 50. Japan Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2019-2030) & (USD Million)
Figure 51. South Korea Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2019-2030) & (USD Million)
Figure 52. India Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2019-2030) & (USD Million)
Figure 53. Southeast Asia Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2019-2030) & (USD Million)
Figure 54. Australia Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2019-2030) & (USD Million)
Figure 55. South America Cell and Gene Therapy Supply Chain and Logistics Consumption Value Market Share by Type (2019-2030)
Figure 56. South America Cell and Gene Therapy Supply Chain and Logistics Consumption Value Market Share by Application (2019-2030)
Figure 57. South America Cell and Gene Therapy Supply Chain and Logistics Consumption Value Market Share by Country (2019-2030)
Figure 58. Brazil Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2019-2030) & (USD Million)
Figure 59. Argentina Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2019-2030) & (USD Million)
Figure 60. Middle East and Africa Cell and Gene Therapy Supply Chain and Logistics Consumption Value Market Share by Type (2019-2030)
Figure 61. Middle East and Africa Cell and Gene Therapy Supply Chain and Logistics Consumption Value Market Share by Application (2019-2030)
Figure 62. Middle East and Africa Cell and Gene Therapy Supply Chain and Logistics Consumption Value Market Share by Country (2019-2030)
Figure 63. Turkey Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2019-2030) & (USD Million)
Figure 64. Saudi Arabia Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2019-2030) & (USD Million)
Figure 65. UAE Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2019-2030) & (USD Million)
Figure 66. Cell and Gene Therapy Supply Chain and Logistics Market Drivers
Figure 67. Cell and Gene Therapy Supply Chain and Logistics Market Restraints
Figure 68. Cell and Gene Therapy Supply Chain and Logistics Market Trends
Figure 69. Porters Five Forces Analysis
Figure 70. Manufacturing Cost Structure Analysis of Cell and Gene Therapy Supply Chain and Logistics in 2023
Figure 71. Manufacturing Process Analysis of Cell and Gene Therapy Supply Chain and Logistics
Figure 72. Cell and Gene Therapy Supply Chain and Logistics Industrial Chain
Figure 73. Methodology
Figure 74. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Discussion of all the project requirements and queries

Validation and triangulation of secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

btl

Companies Mentioned

Be The Match BioTherapies
Biocair
Marken
World Courier
MAK-SYSTEM
Cryoport
Brooks Life Sciences
Clarkston Consulting
Hypertrust Patient Data Care
Haemonetics
MasterControl
TraceLink
SAVSU Technologies
TrakCel
Title21 Health Solutions
sedApta Group
Vineti
Stafa Cellular Therapy
Thermo Fisher Scientific
McKesson
BioLife Solutions
jiaGou

Add To Cart

gouMai

Buy Now